AI X BIO retweeted
imho, in the next 2 years 50%+ of what we watch will come from AI influencers
Welcome @claudia_popstar by @anabology: the first AI influencer on unfair.so!
Made with @heyglif
AI X BIO retweeted
Career update/news including that I'm hiring!
Late in the summer, I made the jump to @AnthropicAI to help co-lead a moonshot effort in genetic medicine.
I'm hoping to have a proper update to share publicly fairly soon, but if you know my collection of interests (AI, clinical genetics, therapeutics, rare disease non-profits), you are unlikely to be surprised. Much of the upfront effort here requires infra for moving atoms as well as bits, and we explicitly want to lean deeply into collaborations with academics, non-profits, and key industry partners in the space. If either of the below roles sound like you, please apply through the link. More to come!
Program Manager:
job-boards.greenhouse.io/ant…
CMC and Manufacturing Lead:
job-boards.greenhouse.io/ant…
AI X BIO retweeted
Last week, we officially introduced Ladon, our biological foundation model that predicts survival and treatment response in patients. This was a huge effort from the @blankbio_ team, and we’ve got more to share soon on how Ladon can accelerate us towards a future of clinical trial abundance.
It was fun to sit down with my co-founders, @phil_fradkin and @ianshi3, and discuss more behind-the-scenes details of the model. We went through some of the motivations behind building the model, our hypotheses that informed early development decisions, key differences in modeling biological data vs. text, the scaling laws in biology, and more.
1:28 Intro
2:23 What is Ladon?
3:23 Why start with RNA-seq?
7:19 Why we built it, and who it's for
12:44 Prognostic vs. predictive biomarkers
18:49 How modeling biology is different from text
20:29 Ladon: sequence-aware + multi-species
25:02 Observing scaling laws in biology
27:46 Generative capabilities and accelerating trials
32:03 Clinical trial abundance
AI X BIO retweeted
After 6 years in stealth, Aether's first paper is out.
We designed and measured hundreds of proteins. The ones that leading models were most confident in were least likely to work: 84% didn't bind.
A confident predicted shape is not evidence of function.
AI X BIO retweeted
🆕 cuPotential
A CUDA-X library for computing nonbonded interactions in molecular dynamics. The OpenMM plugin replaces the nonbonded force, integrator, and barostat.
In NPT benchmarks on systems from 24K to 400K atoms, it ran over 3x faster than OpenMM on RTX PRO 6000 Blackwell and about 2x faster on B200, H100, A100, L40S, A10, L4, and T4.
Accuracy holds up too, with a few hundred times less energy drift than default PME.
💻 Github nvda.ws/3WIwogJ
📄 Technical Blog nvda.ws/4AyIpDX
📍 Find us at #SC26 👇
AI X BIO retweeted
This is a dream moment. I started writing MD on GPU 16 years ago. And since then progress in computing has largely been decoupled from progress in first principles molecular simulation.
3x OOTB acceleration with #cuPotential represents the largest single improvement in performance for FEP and the increasingly massive workload generating synthetic data for understanding the biological and chemical world.
It also eclipses the accumulated performance gains of the last decade on GPU in a single library.
And we are just getting started.
🆕 cuPotential
A CUDA-X library for computing nonbonded interactions in molecular dynamics. The OpenMM plugin replaces the nonbonded force, integrator, and barostat.
In NPT benchmarks on systems from 24K to 400K atoms, it ran over 3x faster than OpenMM on RTX PRO 6000 Blackwell and about 2x faster on B200, H100, A100, L40S, A10, L4, and T4.
Accuracy holds up too, with a few hundred times less energy drift than default PME.
💻 Github nvda.ws/3WIwogJ
📄 Technical Blog nvda.ws/4AyIpDX
📍 Find us at #SC26 👇
A new Case Study maps ophthalmology AI research against workforce capacity and blindness burden, showing how concentrated AI development in high-income countries could worsen global health inequities. Learn more: nejm.ai/4aPRgqG
#ArtificialIntelligence #AIinMedicine
AI X BIO retweeted
As biotech becomes one of the defining technologies that will shape economic strength, national resilience and geopolitical influence over the coming decades, the industry must commit to rebuilding and preserving public trust in the face of growing pressures on the institutions that underpin scientific leadership nature.com/articles/s41587-0…
rdcu.be/fxOKG
AI X BIO retweeted
An AI biologist augmented discovery of disease mechanisms and targets for drug treatment.
Working autonomously, trained with >24 million publications and >600TB of biomedical data
@natBME
nature.com/articles/s41551-0…
AI X BIO retweeted
Important editorial @Nature on the new "AI-scientist" papers
"AI scientists can and should empower human
researchers. They cannot and should not replace them."
nature.com/articles/d41586-0…
A big day for multi-agent AI to accelerate biomedical discovery, hypothesis generation, designing experiments with proof points of new candidate drugs (cancer, fibrosis, macular degeneration, antimicrobial resistance, and more)
2 @Nature reports @GoogleDeepMind @FutureHouseSF
nature.com/articles/s41586-0…
nature.com/articles/s41586-0…
AI X BIO retweeted
Today we announced a landmark partnership with @EliLillyandCo to use our AI models to design recombinases for genetic medicine—a collaboration valued at up to $2.25 billion before royalties.
The goal: use Profluent's AI models to design recombinase editors capable of inserting long stretches of DNA at precise locations in the genome.
Read the press release for more: businesswire.com/news/home/2…
AI X BIO retweeted
⚡ Accelerate your molecular clustering with nvMolKit and NVIDIA GPUs
Our new guest post on Greg Landrum's RDKit blog breaks down how to achieve over 200x speedups on a local RTX 5080, and well over 1,000x on datacenter GPUs.
Read the full breakdown and grab the code 🧵
Across large, multicohort datasets, CardioNets achieved superior performance to ECG-only baselines and diagnostic accuracy comparable to CMR-based models, supporting its potential to expand access to advanced cardiovascular assessment. Full study results: nejm.ai/4166ulW
AI X BIO retweeted
Our review on AI for protein engineering is out now, about this too-fast-moving field full of hype and overclaim, yet one that is having a real impact on the world and can be described in a coherent manner without histrionics
science.org/eprint/666XRGRCV…
AI X BIO retweeted
A @nchembio study led by Assoc. Prof. @Michael_A_Erb describes a strategy to deliberately discover “molecular glue” degraders by converting existing protein binders into compounds that recruit the cell’s disposal machinery, selectively degrading ENL and BRD4. More: ow.ly/Fqrr50YoenT
AI X BIO retweeted
Can AI move beyond chatting to actually making biological discoveries? What if AI could think like a microbiologist? 🧪
📣 Excited to introduce Eubiota: a modular agentic AI framework for autonomous discovery in the gut microbiome. 🧬🤖🦠
👉Explore: eubiota.ai/
The gut microbiome is complex; manual discovery is slow. 🐌 We built Eubiota to think like a researcher: planning experiments, verifying data, and synthesizing results. It’s an open-source system designed to empower the entire community. 🌐
Eubiota demonstrated its capability across end-to-end discovery tasks, with results validated in the lab:
✅ Identified uvr-ruv DNA repair axis for fitness under inflammatory stress by screening ~2,000 genes🧬
✅ Designed a microbial consortium therapy to reduce inflammation in mice colitis models.🐁
✅ Uncovered diet-associated anti-inflammatory metabolites & engineered antibiotic cocktails.💊
Eubiota is the "scientific copilot" the field has been waiting for. Let AI be your partner to accelerate discovery! 🚀
Incredible teamwork with @lupantech and all our co-authors! I'm deeply grateful for the guidance from amazing advisors @james_y_zou, @LabSonnenburg, and brilliant mentors KC Huang, @YejinChoinka.
Read more here: 🔗biorxiv.org/content/10.64898…
Code: github.com/lupantech/Eubiota
Try out our system in your browser! 🤖app.eubiota.ai/chat
#Eubiota #AI4Science #Gut #Microbiome #AgenticAI
AI X BIO retweeted
Protein–protein interactions (PPIs) are key to discovering and interpreting new biological functions.
We’re excited to introduce 𝑭𝒍𝒂𝒔𝒉𝑷𝑷𝑰: a new application of gLM2 that uses genomic language modeling to predict proteome-wide PPIs in microbial genomes in minutes.
AI X BIO retweeted
Researchers use #AI and Reverse Vaccinology 2.0 on human blood samples to identify a potential new mpox target, and use the target in a vaccine that elicited mpox-neutralizing antibodies in mice. @ScienceTM scim.ag/4iQkBUy
AI X BIO retweeted
📣 AI predictions in 2026: @StanfordHAI experts envision 2026 as a year defined by rigor, transparency, and a long-overdue focus on actual utility over speculative promise. Read more: hai.stanford.edu/news/stanfo…
AI X BIO retweeted
AI agents for science are featured as a “Method to Watch” in @NatureMethods, nature.com/articles/s41592-0…
The piece also highlights our roadmap outlining capabilities, the need for thorough evaluations, and open challenges for AI agents, cell.com/cell/fulltext/S0092…


































